News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection inColombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Statements 15 Oct 2018 DNDi North America submits brief to the Canadian Standing Committee on Health (HESA) Study on Federally Funded Health Research
Statements 10 Sep 2018 DNDi contribution to the World Health Organization roadmap on access to medicines and vaccines 2019-2023
Statements 24 May 2018 DNDi and MMV, supported by Unitaid, deliver statement about R&D and access to child-friendly medicines at the 71st World Health Assembly
Statements 27 Jan 2018 Medicines for Malaria Venture and DNDi deliver statement on R&D for children-friendly medicines at WHO EB142
Statements 21 Sep 2016 DNDi Welcomes the Political Declaration of the United Nations High-Level Meeting on Antimicrobial Resistance
Statements 14 Sep 2016 DNDi response to the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines
Statements 27 May 2016 DNDi delivers statement about CEWG on R&D Financing and Coordination at 69th World Health Assembly
Statements 11 Jul 2014 Demonstration Financing: Considerations for a Pilot Pooled International Fund for R&D
Statements 2 Dec 2011 Call to Action for Latin America to Boost Innovation and Access for Neglected Patients in the Region
